Clonidine and Verapamil Interaction

Drug interaction information between Clonidine and Verapamil.

Clonidine and Verapamil have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Clonidine and Verapamil. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Clonidine

Central Alpha-2 Agonist

Drug B

Verapamil

Calcium Channel Blocker

How They Interact

Using these two drugs at the same time can cause a very slow heart rate that might require a hospital stay.

FDA Label Information

Sinus bradycardia resulting in hospitalization and pacemaker insertion has been reported in association with the use of clonidine concomitantly with diltiazem or verapamil.

Clonidine Also Interacts With

View all Clonidine interactions →

Frequently Asked Questions

What SPL severity band is on file for Clonidine + Verapamil?

Compiled FDA labeling labels this pair minor. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Verapamil has 57 labeled pairs on file vs Clonidine's 29. In the minor band specifically: Clonidine has 25 (also Amitriptyline, Diltiazem, Haloperidol, Amiodarone); Verapamil has 47 (also Atorvastatin, Aspirin, Atenolol, Timolol).

What mechanism field is on file for Clonidine and Verapamil?

Using these two drugs at the same time can cause a very slow heart rate that might require a hospital stay.

Verapamil carries more major-labeled pairs than Clonidine

SPL source-record counts only. This page's band is minor · classes on file: Clonidine (Central Alpha-2 Agonist); Verapamil (Calcium Channel Blocker).

Verapamil has 4 major-labeled pairs vs Clonidine's 0. This page itself is in the minor band, not the major band.

Clonidine

0 major · 4 moderate · 25 minor · 29 total

Verapamil

4 major · 6 moderate · 47 minor · 57 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.